Groenen P, Wieringa B
Department of Cell Biology and Histology, Medical Faculty, University of Nijmegen, The Netherlands.
Bioessays. 1998 Nov;20(11):901-12. doi: 10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0.
Myotonic dystrophy (DM) is a highly variable multisystemic disease belonging to the rather special class of trinucleotide expansion disorders. DM results from dynamic expansion of a perfect (CTG)n repeat situated in a gene-dense region on chromosome 19q. Based on findings in patient materials or cellular and animal models, many mechanisms for the causes and consequences of repeat expansion have been proposed; however, none of them has enjoyed prolonged support. There is now circumstantial evidence that long (CTG)n repeats may affect the expression of any of at least three genes, myotonic dystrophy protein kinase (DMPK), DMR-N9 (gene 59), and a DM-associated homeodomain protein (DMAHP). Furthermore, the new findings suggest that DM is not a simple gene-dosage or gain-or-loss-of-function disorder but that entirely new pathological pathways at the DNA, RNA, or protein level may play a role in its manifestation.
强直性肌营养不良(DM)是一种高度可变的多系统疾病,属于相当特殊的三核苷酸重复扩增疾病类别。DM是由位于19号染色体基因密集区域的完美(CTG)n重复序列动态扩增所致。基于患者材料或细胞及动物模型的研究结果,已经提出了许多关于重复扩增的原因和后果的机制;然而,没有一种机制得到长期支持。现在有间接证据表明,长(CTG)n重复序列可能影响至少三个基因中的任何一个的表达,即强直性肌营养不良蛋白激酶(DMPK)、DMR-N9(基因59)和一种与DM相关的同源结构域蛋白(DMAHP)。此外,新的研究结果表明,DM不是一种简单的基因剂量或功能获得或丧失性疾病,而是DNA、RNA或蛋白质水平上全新的病理途径可能在其表现中起作用。